series-c-plus
Stage
1
Investors
About
Inherent Biosciences develops molecular diagnostic tests that use epigenetic biomarkers and AI to assess and improve reproductive health and fertility outcomes.
Explore Inherent Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.